Stockscreener 앱 받기
85.61
3.04%
-2.68
Apogee Therapeutics Inc 주식(APGE)의 최신 뉴스
Apogee Therapeutics, Inc. ($APGE) CEO 2025 Pay Revealed - Quiver Quantitative
Apogee Therapeutics Announces Upcoming Board Resignations, Governance Shift - TipRanks
Apogee Therapeutics (APGE) 2026 meeting to vote on directors, pay and auditor - Stock Titan
Two directors resign from Apogee Therapeutics (NASDAQ: APGE) board, shrinking it to seven - Stock Titan
Certain Common Stock of Apogee Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-APR-2026. - marketscreener.com
Certain Pre-Funded Warrants of Apogee Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-APR-2026. - marketscreener.com
Certain Restricted Stock Units of Apogee Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-APR-2026. - marketscreener.com
APGE stock up as skin disease drug shows sustained 52-week efficacy - MSN
Apogee Thera (APGE) Stock Price Target | Q4 2025: Earnings Beat EstimatesTrending Volume Leaders - Cổng thông tin điện tử Tỉnh Sơn La
Apogee Therapeutics rises on positive phase 2 data for Zumilokibart in atopic dermatitis - MSN
APGE (Apogee Therapeutics Inc.) posts narrower Q4 2025 loss than estimates, shares rise modestly after its latest quarterly earnings release.GDR - Cổng thông tin điện tử tỉnh Tây Ninh
APGE (Apogee Therapeutics Inc.) Q4 2025 EPS outpaces forecasts, shares gain as investors reward narrower than expected loss.Social Flow Trades - UBND thành phố Hải Phòng
APGE Earnings History & Surprises | EPS & Revenue Results | APOGEE THERAPEUTICS INC (NASDAQ:APGE) - ChartMill
Apogee Therapeutics (APGE) CEO exercises options, holds 1.14M shares - Stock Titan
Apogee Therapeutics stock hits all-time high at 92.48 USD By Investing.com - Investing.com India
Insider Sell: Jane Henderson Sells 2,000 Shares of Apogee Therap - GuruFocus
Apogee Therapeutics CFO Henderson sells $180,000 in stock - Investing.com
Apogee Therapeutics CFO Henderson sells $180,000 in stock By Investing.com - Investing.com India
Apogee Therapeutics (APGE) CFO sells 2,000 shares under 10b5-1 plan - Stock Titan
Apogee Therapeutics stock hits all-time high at 92.48 USD - Investing.com
Apogee Therapeutics (NASDAQ:APGE) Reaches New 1-Year HighStill a Buy? - MarketBeat
(APGE) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Apogee Therapeutics Insider Sold Shares Worth $1,651,664, According to a Recent SEC Filing - Moomoo
How Investors May Respond To Apogee Therapeutics (APGE) CEO Share Sale and US$403 Million Equity Raise - Sahm
Apogee Therapeutics Inc. (NASDAQ:APGE) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Aug PreEarnings: Will Apogee Therapeutics Inc benefit from seasonalityPortfolio Return Report & Expert Approved Trade Ideas - baoquankhu1.vn
Dow Update: Should value investors consider Apogee Therapeutics IncQuarterly Market Summary & Accurate Technical Buy Alerts - baoquankhu1.vn
Insider Selling: Apogee Therapeutics (NASDAQ:APGE) CEO Sells 20,000 Shares of Stock - MarketBeat
Apogee Therapeutics CEO Henderson sells $1.65 million in stock By Investing.com - Investing.com Australia
Apogee Therapeutics CEO Henderson sells $1.65 million in stock - Investing.com
Apogee Therapeutics (APGE) CEO sells 20,000 shares under Rule 10b5-1 plan - Stock Titan
Aberdeen Group plc Lowers Stake in Apogee Therapeutics Inc. $APGE - MarketBeat
Apogee Therapeutics stock hits all-time high at 85.95 USD By Investing.com - Investing.com Australia
Apogee Therapeutics (NASDAQ:APGE) Hits New 12-Month HighStill a Buy? - MarketBeat
Apogee Therapeutics stock hits all-time high at 85.95 USD - Investing.com
T. Rowe Price (APGE) discloses 10.29M shares, 16.8% stake in Apogee - Stock Titan
Trade Recap: Whats the beta of Apogee Therapeutics Inc stockWatch List & Fast Moving Stock Watchlists - baoquankhu1.vn
4.01%
0.61%
자본화:
|
볼륨(24시간):